Persistence Capital Partners invests in LMC Diabetes & Endocrinology
Canadian healthcare private equity firm Persistence Capital Partners (PCP) has made an investment in LMC Diabetes & Endocrinology, a Canadian endocrinology practice. The financial terms of the deal were not released. Operating with a network of nine clinics in Alberta, Ontario and Québec, LMC provides community-based care to diabetics and endocrinology patients with a focus on education, research, service excellence and meeting medical needs. The company's partnership with PCP is intended to support growth of its model across Canada. The investment follows PCP's acquisition last month of the occupational health clinical services business of Morneau Shepell Inc.
10 November 2014•3 mins read
